1. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency
- Author
-
Qiang Pan-Hammarström, Chonghai Liu, Ulf Wagner, Michael Borte, Stephan Borte, Dagmar Graf, Ulrich Sack, Lennart Hammarström, and Publica
- Subjects
Immunoglobulin A ,Immunology ,Gene Expression ,Immunoglobulins ,Apoptosis ,Stimulation ,In Vitro Techniques ,Selective IgA deficiency ,Immunoglobulin E ,Biochemistry ,CD19 ,Interleukin 21 ,medicine ,Humans ,RNA, Messenger ,B-Lymphocytes ,biology ,Interleukins ,Common variable immunodeficiency ,IgA Deficiency ,Interleukin-21 Receptor alpha Subunit ,Cell Differentiation ,Drug Synergism ,Cell Biology ,Hematology ,medicine.disease ,Immunoglobulin Class Switching ,Recombinant Proteins ,Interleukin-10 ,Common Variable Immunodeficiency ,Case-Control Studies ,Immunoglobulin G ,biology.protein ,Interleukin-2 ,Interleukin-4 ,Antibody - Abstract
Interleukin-21 (IL-21) is an important promoter for differentiation of human B cells into immunoglobulin (Ig)–secreting cells. The objective of this study was to evaluate an IL-21–based approach to induce immunoglobulin production in B cells from patients with common variable immunodeficiency (CVID) or selective IgA deficiency (IgAD). We show that a combination of IL-21, IL-4, and anti-CD40 stimulation induces class-switch recombination to IgG and IgA and differentiation of Ig-secreting cells, consisting of both surface IgG+ (sIgG+) and sIgA+ B cells and CD138+ plasma cells, in patients with CVID or IgAD. Stimulation with IL-21 was far more effective than stimulation with IL-4 or IL-10. Moreover, spontaneous apoptosis of CD19+ B cells from patients with CVID or IgAD was prevented by a combination of IL-21, IL-4, and anti-CD40 stimulation. Analysis of IL-21 and IL-21 receptor (IL-21R) mRNA expression upon anti-CD3 stimulation of T cells, however, showed no evidence for defective IL-21 expression in CVID patients and sequencing of the coding regions of the IL21 gene did not reveal any mutations, suggesting a regulatory defect. Thus, our work provides an initial basis for a potential therapeutic role of IL-21 to reconstitute immunoglobulin production in CVID and IgAD.
- Published
- 2009
- Full Text
- View/download PDF